The Long-Acting Cabotegravir Tail as an Implementation Challenge: Planning for Safe Discontinuation

Meyers, K., Nguyen, N., Zucker, J. E., Kutner, B. A., Carnevale, C., Castor, D., Sobieszczyk, M. E., Yin, M. T., Golub, S. A., & Remien, R. H. (2022). The Long-Acting Cabotegravir Tail as an Implementation Challenge: Planning for Safe Discontinuation. AIDS and Behavior, 27(1), 4–9. https://doi.org/10.1007/s10461-022-03816-0
Authors:
Kathrine Meyers
Nadia Nguyen
Jason E Zucker
Bryan A Kutner
Caroline Carnevale
Delivette Castor
Magdalena E Sobieszczyk
Michael T Yin
Sarit A Golub
Robert H Remien
Affiliated Authors:
Kathrine Meyers
Nadia Nguyen
Jason E Zucker
Bryan A Kutner
Caroline Carnevale
Delivette Castor
Magdalena E Sobieszczyk
Michael T Yin
Robert H Remien
Columbia Affiliation:
Subjects:
Anti-HIV Agents (MeSH)
HIV Infections (MeSH)
Pre-Exposure Prophylaxis (MeSH)
HIV Integrase Inhibitors (MeSH)
Author Keywords:
prep
cabotegravir
drug level monitoring
implementation
elink
Publication Type:
Article
Unique ID:
10.1007/s10461-022-03816-0
PMID:
36056997
DOI:
10.1007/s10461-022-03816-0
Journal:
AIDS and Behavior
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: